Speakers at a congressional briefing on July 22 called on the FDA to take action against the marketing and distribution of ...

(Reuters) -Novo Nordisk on Tuesday appointed insider Mike Doustdar as its new chief executive after the Danish obesity drug maker cut its full year outlook for the second time in 2025, sending its ...

Investing.com -- Novo Nordisk (NYSE: NVO )’s guidance reduction and CEO resignation represent a "double surprise" according to BMO Capital Markets analyst Evan David Seigerman. In a note to clients, ...

Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Florida Members of Congress Sound Alarm on Surge of Counterfeit Weight Loss Drugs, Urge FDA Action A bipartisan group of U.S.

Comedian and Emmy-nominated actor Kym Whitley opens up about her long journey with weight management. The "Happy Gilmore 2" ...

There's been plenty of buzz about this class of drug, following publication of a high-profile trial this year. How much do we ...

Significantly lower risks seen for those receiving GLP-1 receptor agonists compared with other antidiabetic drugs.

Eli Lilly & Company (NYSE: LLY) ranks among the best low volatility stocks to buy according to analysts. On July 11, ...